相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Poor Long-Term Renal Allograft Survival in Patients with Chronic Antibody-Mediated Rejection, Irrespective of Treatment-A Single Center Retrospective Study
Kaiyin Wu et al.
JOURNAL OF CLINICAL MEDICINE (2022)
Everolimus Reduces Cancer Incidence and Improves Patient and Graft Survival Rates after Kidney Transplantation: A Multi-Center Study
Ryoichi Imamura et al.
JOURNAL OF CLINICAL MEDICINE (2022)
Five-year Outcome of an Early Everolimus-based Quadruple Immunosuppression in Lung Transplant Recipients: Follow-up of the 4EVERLUNG Study
Nikolaus Kneidinger et al.
TRANSPLANTATION (2022)
Change in Estimated GFR and Risk of Allograft Failure in Patients Diagnosed With Late Active Antibody-mediated Rejection Following Kidney Transplantation
William Irish et al.
TRANSPLANTATION (2021)
Pure T-cell mediated rejection following kidney transplant according to response to treatment
Hyunwook Kwon et al.
PLOS ONE (2021)
Recommended Treatment for Antibody-mediated Rejection After Kidney Transplantation: The 2019 Expert Consensus From the Transplantion Society Working Group
Carrie A. Schinstock et al.
TRANSPLANTATION (2020)
The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell- and antibody-mediated rejection
Alexandre Loupy et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2020)
Response to treatment and long-term outcomes in kidney transplant recipients with acute T cell-mediated rejection
Yassine Bouatou et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2019)
Efficacy and safety of everolimus plus low-dose calcineurin inhibitor vs. mycophenolate mofetil plus standard-dose calcineurin inhibitor in renal transplant recipients: A systematic review and meta-analysis
Lihong He et al.
CLINICAL NEPHROLOGY (2018)
Everolimus with Reduced Calcineurin Inhibitor Exposure in Renal Transplantation
Julio Pascual et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)
The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology
A. Loupy et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2017)
De novo cancer in patients on dialysis and after renal transplantation: north-western Italy, 1997-2012
Valentina Mazzucotelli et al.
JOURNAL OF NEPHROLOGY (2017)
Recomendaciones para el uso de everolimus en trasplante renal de novo: falsas creencias, mitos y realidades
Julio Pascual et al.
NEFROLOGIA (2017)
Efficacy and Safety of Everolimus for Maintenance Immunosuppression of Kidney Transplantation: A Meta-Analysis of Randomized Controlled Trials
Jinyu Liu et al.
PLOS ONE (2017)
Association of Clinical Events With Everolimus Exposure in Kidney Transplant Patients Receiving Low Doses of Tacrolimus
F. Shihab et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2017)
Long-term graft survival in patients with chronic antibody-mediated rejection with persistent peritubular capillaritis treated with intravenous immunoglobulin and rituximab
William R. Mulley et al.
CLINICAL TRANSPLANTATION (2017)
CMV and BKPyV Infections in Renal Transplant Recipients Receiving an mTOR Inhibitor Based Regimen Versus a CNI-Based Regimen: A Systematic Review and Meta-Analysis of Randomized, Controlled Trials
Samir G. Mallat et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Calcineurin Inhibitor Minimization, Conversion, Withdrawal, and Avoidance Strategies in Renal Transplantation: A Systematic Review and Meta-Analysis
D. Sawinski et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2016)
Early conversion from cyclosporine to everolimus following living-donor kidney transplantation: outcomes at 5 years post-transplant in the randomized ZEUS trial
Claudia Sommerer et al.
CLINICAL NEPHROLOGY (2016)
Current outcomes of chronic active antibody mediated rejection - A large single center retrospective review using the updated BANFF 2013 criteria
Robert R. Redfield et al.
HUMAN IMMUNOLOGY (2016)
Experience with belatacept rescue therapy in kidney transplant recipients
Susanne Brakemeier et al.
TRANSPLANT INTERNATIONAL (2016)
mTOR Inhibition Suppresses Posttransplant Alloantibody Production Through Direct Inhibition of Alloprimed B Cells and Sparing of CD8+Antibody-Suppressing T cells
Christina L. Avila et al.
TRANSPLANTATION (2016)
n Everolimus and Malignancy after Solid Organ Transplantation: A Clinical Update
Hallvard Holdaas et al.
JOURNAL OF TRANSPLANTATION (2016)
Reduced Incidence of Cytomegalovirus Infection in Kidney Transplant Recipients Receiving Everolimus and Reduced Tacrolimus Doses
H. Tedesco-Silva et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2015)
Renal, efficacy and safety outcomes following late conversion of kidney transplant patients from calcineurin inhibitor therapy to everolimus: the randomized APOLLO study
Klemens Budde et al.
CLINICAL NEPHROLOGY (2015)
Five-Year Outcomes in Kidney Transplant Patients Converted From Cyclosporine to Everolimus: The Randomized ZEUS Study
K. Budde et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2015)
Renal function to 5 years after late conversion of kidney transplant patients to everolimus: a randomized trial
Klemens Budde et al.
JOURNAL OF NEPHROLOGY (2015)
Everolimus-based calcineurin-inhibitor sparing regimens for kidney transplant recipients: a systematic review and meta-analysis
Liya Su et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2014)
Incidence of Primary and Second Cancers in Renal Transplant Recipients: A Multicenter Cohort Study
G. Tessari et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
Conversion from everolimus with low-exposure cyclosporine to everolimus with mycophenolate sodium maintenance therapy in kidney transplant recipients: A randomized, open-label multicenter study
Jacques Dantal
Annals of Transplantation (2013)
Effector Mechanisms of Rejection
Aurelie Moreau et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2013)
Review of combination therapy with mTOR inhibitors and tacrolimus minimization after transplantation
V. Ram Peddi et al.
TRANSPLANTATION REVIEWS (2013)
Risk Factors for Steroid-Resistant T-Cell Mediated Acute Cellular Rejection and Their Effect on Kidney Graft and Patient Outcome
Waleed Awadain et al.
EXPERIMENTAL AND CLINICAL TRANSPLANTATION (2012)
Organ Transplantation 3 Diagnosis and prevention of chronic kidney allograft loss
Brian J. Nankivell et al.
LANCET (2011)
Organ Transplantation 2 Prevention of cardiovascular disease in adult recipients of kidney transplants
Alan G. Jardine et al.
LANCET (2011)
Conversion of Long-Term Kidney Transplant Recipients From Calcineurin Inhibitor Therapy to Everolimus: A Randomized, Multicenter, 24-Month Study
Hallvard Holdaas et al.
TRANSPLANTATION (2011)
A New Equation to Estimate Glomerular Filtration Rate
Andrew S. Levey et al.
ANNALS OF INTERNAL MEDICINE (2009)
Immunoregulatory functions of mTOR inhibition
Angus W. Thomson et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Chronic allograft nephropathy
Behzad Najafian et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2008)
Predictors of success in conversion from calcineurin inhibitor to sirolimus in chronic allograft dysfunction
F Diekmann et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2004)
The risk of cardiovascular disease associated with proteinuria in renal transplant patients
G Fernández-Fresnedo et al.
TRANSPLANTATION (2002)
Proteinuria after renal transplantation affects not only graft survival but also patient survival
JL Roodnat et al.
TRANSPLANTATION (2001)
分享论文
